Results

Total Results: 2,794 records

Showing results for "policymakers".

241. How the CHIPRA quality demonstration elevated children on State health policy agendas (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/highlight04.pdf
     September 08, 2015 - Leveraging CHIPRA activities to obtain buy-in from policymakers Obtaining—and sustaining—buy-in from … State policymakers is also an important part of ensuring that the work being done under the CHIPRA … Even in cases where policymakers are supportive of project goals, they must weigh these goals against … data and analysis collected through the CHIPRA quality demonstration to support efforts to educate policymakers … Such ongoing dialogue can provide a vehicle for policymakers to obtain input on policies that may

242. The New England RAPiD (Regional Adaptation for Payer Policy Decisions) Project (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/iadapt/pearson.pdf
     December 17, 2014 - this project was to adapt AHRQ evidence reviews to enhance their application by payers and other policymakers

243. Slide 1 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/module_iii2.ppt
     May 29, 2025 - encouraged to identify and nominate topics for research, including patients and consumers, clinicians, policymakers … relevant professional and consumer organizations, insurers and health plan representatives, public policymakers … for clinicians through professional organizations and societies, or certification boards Look for policymakers … potential end-users are invited to participate during this phase, including consumers, clinicians, and policymakers … organizations Support groups Clinicians Professional organizations and societies Certification boards Policymakers

244. S44 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s44.pdf
     October 01, 2007 - Results: DD trials deviated from ideal PRTs in the policymakers’ domain: the policies affected mixtures … Aspects negotiated by researchers and policymakers also deviated from ideal: length of delay; size and … Conclusions: DD trials can be negotiated with policymakers. … Participants were trialists, epidemiologists, journal editors, and policymakers who had conducted PRTs … The Domain of Negotiation Between Researchers and Policymakers Reuse of the Same Controls.

245. 2. Synthesis of Key Findings by Category | Agency for Healthcare Research and Quality
     www.ahrq.gov/policymakers/chipra/demoeval/what-we-learned/final-report/section2.html
     October 01, 2015 - agendas, demonstration States leveraged the CHIPRA grant to develop or strengthen connections to key policymakers … agendas, demonstration States leveraged the CHIPRA grant to develop or strengthen connections to key policymakers … Demonstration States reported that the presence of a CHIPRA grant sent State policymakers a signal about … learned how to leverage data and analysis generated through the CHIPRA quality demonstration to engage policymakers … Common to all of these efforts, however, were the new connections formed among State officials, policymakers

246. Info FAQs | Agency for Healthcare Research and Quality
     www.ahrq.gov/faqs/index.html?page=16
     January 01, 2014 - Those findings can be found at https://www.ahrq.gov/policymakers/chipra/demoeval/index.html . … suggestions to the EPC program for a new evidence review can be submitted by the public, such as clinicians, policymakers … suggestions to the EPC program for a new evidence review can be submitted by the public, such as clinicians, policymakers

247. Annual Conference on Health Information Technology & Analytics (CHITA) | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/annual-conference-health-information-technology-analytics-chita
     January 01, 2023 - CHITA solicited papers around a range of HIT+A topics and connected HIT+A academic disciplines with policymakers … dissemination of yearly HIT+A research agendas, the findings from the annual CHITA informed a broad range of policymakers

248. Measure: Post-Partum Followup and Care Coordination (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p009-3-ef.pdf
     January 01, 2015 - related to prenatal/perinatal performance, see the list of COE-submitted measures at http://www.ahrq.gov/policymakers

249. Designing Care Management Entities for Youth with Complex Behavioral Health Needs | Agency for Healthcare Research and Quality
     www.ahrq.gov/policymakers/chipra/demoeval/what-we-learned/implementation-guides/implementation-guide2/index.html
     September 01, 2014 - about the national evaluation and the CHIPRA quality demonstration is available at http://www.ahrq.gov/policymakers

250. Key Lessons from the National Evaluation of the CHIPRA Quality Demonstration Grant Program (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/finalsummary.pdf
     February 21, 2016 - • Developing reports for policymakers, providers, and consumers to compare performance with national … reported that its efforts ultimately yielded robust and useful reports for practices, families, and policymakers … Federal policymakers were looking to this demonstration to provide information on the use and impact … As Federal and State policymakers chart new directions to stimulate innovation in service delivery systems

251. Endnotes | Agency for Healthcare Research and Quality
     www.ahrq.gov/policymakers/chipra/demoeval/what-we-learned/implementation-guides/implementation-guide2/implguide2ref.html
     September 01, 2014 - http://www.ahrq.gov/policymakers/chipra/demoeval/what-we-learned/implementation-guides/implementation-guide1 … http://www.ahrq.gov/policymakers/chipra/demoeval/what-we-learned/highlight06.pdf .

252. Supplement to Evaluation Highlight No. 6: How are CHIPRA quality demonstration States working together to improve the quality of health care for children? (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/supplhighlight06.pdf
     June 02, 2025 - Health Measurement Initiative, a national initiative out of the Oregon Health http://www.ahrq.gov/policymakers … Learn More For additional details on the CHIPRA Demonstration States, see www.ahrq.gov/policymakers … http://www.ahrq.gov/policymakers/chipra/demoeval/demostates/index.html

253. PowerPoint Presentation (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/supln-slides.pdf
     January 24, 2025 - existing data (Medicaid claims, immunization registries) – Develop reports for different stakeholders: policymakers … Results • View evaluation highlights and other materials on the evaluation webpage: www.ahrq.gov/policymakers … /chipra/demoeval/index.html http://www.ahrq.gov/policymakers/chipra/demoeval/index.html Presented …  Evaluate implementation and provide timely feedback to program and policymakers.

254. Agarwal, Ritu | Digital Healthcare Research
     digital.ahrq.gov/principal-investigator/agarwal-ritu
     January 01, 2023 - facilitates the development of research and implementation lessons; fosters relationships among academics, policymakers … Conference on Health IT & Analytics connected a wide range of academic disciplines, Federal agencies, policymakers

255. 0129Table13 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0129table13.pdf
     June 02, 2025 - Table 13 – Analysis of Disparities in Readmission Risk Based on Rurality/Urbanicity Rurality/Urbanicity Level Odds Ratio [95% Confidence Interval] Urban Reference Suburban 0.97 [0.92 - 1.03] Large town 0.99 [0.94 - 1.03] Small town 1.01 [0.96 - 1.07] Rural 1.07 [1.00 - 1.14]

256. 0129Table12 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0129table12.pdf
     June 02, 2025 - Table 12 – Analysis of Disparities in Readmission Risk Based on Insurance Status Insurance Status Odds Ratio [95% Confidence Interval] Medicaid Reference Private insurance 0.76 [0.75 - 0.78] Self-pay 0.73 [0.69 - 0.78] Other (e.g., Medicare or other government- sponsored insurance) 0.85 [0.78 - 0.92]

257. Chipra204-Materials Viic (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_VIIC.pdf
     June 02, 2025 - Table 1. Use of Validated Tool by Insurance Status Reviewer 1 Reviewer 2 Reviewer 1 Reviewer 2 Reviewer 1 Reviewer 2 Reviewer 1 Reviewer 2 Reviewer 1 Reviewer 2 Medicaid 43.96% 39.56% 100.00% 100.00% 100.00% 94.12% 16.67% 33.33% 13.46% 3.85% Private 97.78% 97.78% 100.00% 100.00% n/a n/a 100.00% 100.00% 0.00% 0.00% …

258. Chipra204-Materials Ii (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_II.pdf
     June 02, 2025 - eMeasure Title Follow-up Referral after Positive Developmental Screen eMeasure Identifier (Measure Authoring Tool) 376 eMeasure Version number 0.0.005 NQF Number None GUID d47f5664-bd76-4a65-88aa-f73f6fb6a2c8 Measurement Period January 1, 20xx through December 31, 20xx Measure Steward Agency for Healthcare Resea…

259. Chipra205-Materials Viiia (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_VIIIA.pdf
     June 02, 2025 - EHR Data Feasibility Tool copyright 2011 American Medical Association. All Rights Reserved. This tool and the information contained therein may not be reproduced or distributed and may only be used for collecting data in connection with an agreement with the American Medical Association. THIS TOOL IS PROVIDED …

260. Chipra202-Materials Viic (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA202-Materials_VIIC.pdf
     June 02, 2025 - Table 1. Use of Validated Tool by Insurance Status Reviewer 1 Reviewer 2 Reviewer 1 Reviewer 2 Reviewer 1 Reviewer 2 Reviewer 1 Reviewer 2 Reviewer 1 Reviewer 2 Medicaid 43.96% 39.56% 100.00% 100.00% 100.00% 94.12% 16.67% 33.33% 13.46% 3.85% Private 97.78% 97.78% 100.00% 100.00% n/a n/a 100.00% 100.00% 0.00% 0.00% …